Eosinophilic Esophagitis Onset Despite Six Years' Treatment With Omalizumab in an Asthmatic Patient: No Protective Effect for Anti-IgE Therapy?

Am J Gastroenterol. 2021 Jul 1;116(7):1560. doi: 10.14309/ajg.0000000000001213.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anti-Asthmatic Agents / therapeutic use*
  • Asthma / complications
  • Asthma / drug therapy*
  • Asthma / immunology
  • Eosinophilic Esophagitis / complications
  • Eosinophilic Esophagitis / diagnosis*
  • Eosinophilic Esophagitis / immunology
  • Female
  • Humans
  • Immunoglobulin E / immunology*
  • Omalizumab / therapeutic use*

Substances

  • Anti-Asthmatic Agents
  • Omalizumab
  • Immunoglobulin E